Last updated on February 2020

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Brief description of study

The aim of the study is to evaluate efficacy and safety of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with preserved ejection fraction

Clinical Study Identifier: NCT03057951

Find a site near you

Start Over

Urasoe General Hospital

Okinawa, Urasoe, Japan
  Connect »

Naha City Hospital

Okinawa, Naha, Japan
  Connect »

Nanbu Tokushukai Hospital

Okinawa, Shimajiri-gun, Japan
  Connect »